Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Operating Margin (2016 - 2025)

Historic Operating Margin for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to 28776.47%.

  • vTv Therapeutics' Operating Margin changed N/A to 28776.47% in Q4 2024 from the same period last year, while for Sep 2025 it was 175382.35%, marking a year-over-year decrease of 1729828500.0%. This contributed to the annual value of 2377.58% for FY2024, which is N/A changed from last year.
  • vTv Therapeutics' Operating Margin amounted to 28776.47% in Q4 2024.
  • vTv Therapeutics' 5-year Operating Margin high stood at 28.6% for Q4 2020, and its period low was 123433.33% during Q4 2021.
  • For the 4-year period, vTv Therapeutics' Operating Margin averaged around 37016.52%, with its median value being 34616.81% (2024).
  • Its Operating Margin has fluctuated over the past 5 years, first surged by 912857400bps in 2020, then plummeted by -1234619300bps in 2021.
  • Over the past 4 years, vTv Therapeutics' Operating Margin (Quarter) stood at 28.6% in 2020, then crashed by -431712bps to 123433.33% in 2021, then surged by 43bps to 70477.78% in 2022, then surged by 59bps to 28776.47% in 2024.
  • Its Operating Margin stands at 28776.47% for Q4 2024, versus 562.7% for Q1 2024 and 70477.78% for Q4 2022.